本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aerovate Therapeutics, Inc.

2.77
+0.02000.73%
盘后2.76-0.0100-0.36%18:09 EDT
成交量:89.37万
成交额:248.41万
市值:8,028.85万
市盈率:-1.14
高:2.84
开:2.76
低:2.71
收:2.75
数据加载中...
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/09

重要事件披露

Form 8-K - Current report
2025/04/09

重要事件披露

Form 8-K - Current report
2025/04/09

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/07

重要事件披露

Form 8-K - Current report
2025/04/07

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/26

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/24

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations